Nothing Special   »   [go: up one dir, main page]

US3645267A - Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate - Google Patents

Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate Download PDF

Info

Publication number
US3645267A
US3645267A US3645267DA US3645267A US 3645267 A US3645267 A US 3645267A US 3645267D A US3645267D A US 3645267DA US 3645267 A US3645267 A US 3645267A
Authority
US
United States
Prior art keywords
output
amplitude
energy
improvement
transistor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Norman R Hagfors
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Application granted granted Critical
Publication of US3645267A publication Critical patent/US3645267A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36034Control systems specified by the stimulation parameters

Definitions

  • the electrical stimulation of nerves, muscles or other tissue is often accompanied by undesirable side effects caused by stimulation of adjacent nerve fibers, for example. It has been discovered that in many cases these side effects are transitory in nature and persist for only a short period of time after stimulus by means of electrical signals is first applied. It is theorized that the stimulating signals, when turned on at full stimulating amplitude, cause the afferent nerve fibers to fire giving a sensation of electrical shock. It appears that these afferent fibers then accommodate to the stimulus signal, and will no longer fire.
  • the apparatus of this invention overcomes the above-mentioned undesirable side effects by providing circuitry for gradually increasing the amplitude of the initial stimulating signals to a predetermined stimulus level. It has been found that if the stimulus is turned on gradually, the afferent nerve fibers accommodate to the stimulus signal without depolarizing and provide little or no sensation of electrical shock, and that the stimulating signals may thereafter be maintained at the predetermined level without adverse reaction. Therefore, the apparatus of this invention has been designed for implantable, transcutaneous, and external stimulators to provide pulse or other stimulus turn-on characteristics which will be accommodated by the afferent nerve fibers to prevent a transitory response.
  • the apparatus of this invention comprises amplifier means connected between a selected portion or all of the circuitry for providing stimulating signals and the source of energy which provides the electrical power to the circuitry.
  • the amplifier means is controlled by electrical time constant circuitry which is connected by switch means across the source of electrical energy.
  • the time constant means is shown as a serial RC circuit, that is, a resistor and a capacitor connected in series. When the switch is closed, the time constant causes a gradual buildup of charge in the capacitor. The charge on the capacitor is used to control the initial output of the amplifier which in turn controls the current reaching the circuitry for providing stimulating signals, in this circuit a train of pulses.
  • the initial amplitude of the train of output pulses will also be gradually increased to its maximum or predetermined level. As described above, this gradual increase of the initial amplitude of the signals which provide stimulus will reduce or remove the transitory response that causes an uncomfortable feeling in the patient receiving the stimulation.
  • FIG. 1 is a combination schematic and block diagram showing an embodiment using the apparatus of this invention
  • FIG. 2 is a schematic diagram of electronic pulse stimulating circuitry using another embodiment of the apparatus of this invention.
  • FIG. 3 is a graph indicating a typical envelope for a train of prior art stimulating pulses.
  • FIG. 4 is a graph indicating the envelope of a train of stimulating pulses provided by the apparatus of this invention.
  • FIG. 1 there is shown in block diagram an electronic stimulator 10.
  • Stimulator 10 has a pair of input terminals 11 and 12 adapted to be connected to a source of electrical energy, and a pair of output terminals 13 and 14 across which the stimulator provides a train of output pulses.
  • a source of electrical energy here shown as batteries 15, is connected between input terminal 11 and one side of a switch 16.
  • the ap paratus of this invention for gradually increasing the initial output amplitude of the stimulating signals is shown enclosed within dotted lines and indicated generally as 20.
  • Apparatus 20 comprises a capacitor 17 and resistor 18 serially connected across source 15 and switch 16.
  • Apparatus 20 also includes a transistor 19, having an emitter connected to input terminal 12, a collector connected to the other side of switch 16, and a base connected to a junction between capacitor 17 and resistor 18.
  • switch 16 is open. Therefore, there will be no charge on capacitor 17 and no output signals from stimulator 10.
  • switch 16 is closed. This will connect the electrical time constant apparatus, comprising the serial RC circuit of capacitor 17 and resistor 18, across source 15. As capacitor 17 cannot charge instantaneously, there will be no current flow through the amplifier comprising transistor 19, and therefore no power to stimulator l0, instantaneously.
  • This gradual increase of the amplitude of only the initial output signals to a maximum or predetermined amplitude is the desired result to alleviate the undesirable feelings caused in the patient receiving the train of pulses, which undesirable feeling is present when the initial turn-on of the train of pulses is at full amplitude and is apparently caused by stimulation of adjacent nerve fibers.
  • FIG. 2 there is shown another embodiment of the apparatus of this invention.
  • the disclosed schematic is that of a radiofrequency pulse transmitter of a type presently in use in the art, for transmitting a train of stimulating pulses via RF to an implanted receiver which is connected to the tissue that is to be stimulated.
  • output terminals 13 and 14, source 15 and switch 16 bear the same numbers as for FIG. 1. Also, the improvement comprising the apparatus of this invention is again enclosed in dotted lines and denoted as 20.
  • Source 15 has one terminal connected to a positive bus 21, and another terminal connected through switch 16 to a negative bus 22.
  • a capacitor 23, for voltage stabilization purposes, is connected between buses 21 and 22.
  • a transistor 24 has its emitter connected to bus 21. The base of transistor 24 is connected through a pair of diodes 25 and 26 to bus 21, and through a resistor 27 and a variable resistor 28 to bus 22.
  • a transistor 30 has its emitter connected to bus 22. The base of transistor 30 is connected through a resistor 33 to the collector of transistor 24, and through a resistor 34 to bus 22.
  • the collector of transistor 30 is connected through a resistor 32 and a capacitor 31 to the base of transistor 24.
  • a transistor 35 has its emitter connected to bus 21.
  • the base of transistor 35 is connected through a resistor 36 to the collector of transistor 30, and through a resistor 37 to bus 21.
  • the collector of transistor 35 is connected through a serial combination of a resistor 38 and a Zener diode 39 to bus 22.
  • a junction between resistor 38 and diode 39 is connected to bus 22 through a serial combination of a potentiometer 40 and a resistor 41.
  • a transistor 42 has its base connected to the wiper arm of potentiometer 40, and its emitter connected through a resistor 43 to a junction 44. Junction 44 is connected through a capacitor 45 to bus 22, and directly to output terminal 13.
  • a pair of serially connected resistors 46 and 47 are connected between junction 44 and bus 22.
  • a transistor 50 has its base connected to a junction between resistors 46 and 47, and its collector connected directly to output terminal 14.
  • a capacitor 51 is connected between the collector and emitter of transistor 50.
  • the emitter of transistor 50 is connected through an RF tank circuit 53 to bus 22.
  • Tank circuit 53 comprises a parallel combination of a variable inductance 54, a capacitor 55 and a capacitor 56.
  • a transistor 60 has its emitter connected to the collector of transistor 42.
  • the collector of transistor 60 is connected to bus 21.
  • the base of transistor 60 is connected through a resistor 61 to bus 21, and through a capacitor 62 to bus 22.
  • a capacitor 63 is connected between the emitter of transistor 60 and bus 22 to provide lower circuit impedance in a manner well known in the art.
  • transistors 24 and 30 and their associated electrical components comprise a pulse generator that will act to provide output pulses as long as switch 16 is closed.
  • switch 16 When switch 16 is closed the voltage from source 15 will be felt between buses 21 and 22. There will be a current flow through diodes 25 and 26, resistor 27 and variable resistor 28. Capacitor 31 will not be charged, and the drop across diodes 25 and 26 will forward bias the emitter-base junction of transistor 24 to turn it on. The tum-on of transistor 24 will cause a current flow through resistors 33 and 34 thus causing a forward bias at the emitter-base junction of transistor to turn it on.
  • transistor 30 When transistor 30 turns on a charging path will be provided for capacitor 31, and when the charge on capacitor 31 has reached a sufficient level it will bias off transistor 24, which will in turn bias off transistor 30. The charge on capacitor 31' will then discharge through the path comprising resistor 37, resistor 36, resistor 32, capacitor 31, resistor 27 and resistor 28. When a sufficient lowering of the charge on capacitor 31 has been accomplished transistor 24 will again turn on and the cycle will repeat. Thus there is an output train of pulses generated as long as switch 16 is closed.
  • transistor 35 and Zener diode 39 comprise a voltage regulator.
  • the output pulse from the pulse generator causes a current flow through resistors 36 and 37 to forward bias the emitter-base junction of transistor 35 thus causing a current flow through resistor 38, potentiometer and resistor 41.
  • Diode 39 acts to regulate the voltage of this portion of the circuit.
  • Transistor 42 in combination with potentiometer 40 operate as an output amplitude adjustment, with the capability of varying the amplitude of the output according to the positioning of the wiper arm of potentiometer 40. Assuming first that the apparatus 20 is not present, and that, as in the prior art, the collector of transistor 42 is connected directly to bus 21, then the current flow through transistor 40 will cause the forward biasing of the emitter-base junction of transistor 42, causing a current flow through resistor 43 to junction 44. This will charge transistor 45 and be felt across the serial combination of resistors 46 and 47.
  • Transistor 50 will then be turned on to provide energy to the tank circuit 53 and the RF oscillator interconnection of these components will cause a train of RF output pulses at terminals 13 and 14, the amplitude of which is controlled by the setting of potentiometer 40.
  • the output of transistor 42 will not be provided to the RF oscillator until the amplifier comprising transistor 60 has been turned on.
  • the time constant apparatus comprising the serial combination of resistor 61 and capacitor 62 across the power supply, controls the tum-on of transistor emitter-follower connected 60. That is, when switch 16 is closed there will have been no charge on capacitor 62 and there will therefore not be an instantaneous forward biasing of the emitterbase junction of transistor 60. As capacitor 62 gradually charges through resistor 61, the forward bias of the emitterbase junction of transistor 60 will gradually increase, and the current flow therethrough to the collector of transistor 42 will correspondingly gradually increase. When capacitor 62 is fully charged then the maximum current flow will be available through transistor 60 and transistor 42.
  • the amplitude of the initial pulses available through transistor 42 to the RF oscillator is gradually increased, and that only the initial pulses of the resulting train of RF pulses will be correspondingly gradually increased.
  • the RF receiver which is connected to the tissue of the patient will receive a train of pulses of which the initial pulses gradually increase in amplitude to a predetermined value, and the possibility of an unpleasant feeling due to the transitory side effects caused by the immediate full amplitude tum-on of the train of pulses will be alleviated.
  • connection of apparatus 20 at the position in the circuitry as shown in FIG. 2 is preferable to that of FIG. 1 for purposes of conservation of energy.
  • the connection possibility suggested in the embodiment of FIG. 1, that is, where the apparatus 20 is placed between the source of energy 15 and all of circuitry 10, is be lieved to be the preferred embodiment for purposes of stability.
  • Other embodiments than those shown in the drawings have been used, for example the placement of apparatus 20 so as to provide gradual increase of power supply voltage to both the voltage regulator and output amplitude adjustment apparatus of FIG. 2, and it will be apparent that the placement of apparatus 20 to select gradual control of any selected portion of the pulse stimulator circuitry is in any case within the scope of this invention.
  • FIGS. 3 and 4 are graphs of the pulse train amplitude versus time for representing the difference between the prior an output pulse trains and the pulse trains from apparatus utilizing this invention.
  • FIG. 3 is a prior art output pulse train where it can be seen that almost instantaneously the train of pulses reaches its full amplitude. It is this sudden rise to full amplitude which is believed to cause the side effects and unpleasant feelings'in the patient, probably due to stimulation of adjacent tissue to the tissue it is desired to stimulate.
  • circuitry for providing output electronic stimulating signals to a selected portion of the body the signals providing a plurality of pulses, the circuitry adapted to be connected to a source of electrical energy, the improvement comprising: means for gradually increasing the amplitude of the initial pulses of the output stimulating signals to a predetermined value; energy terminal means adapted to be connected to the source of electrical energy; and further means for connecting said means for gradually increasing the amplitude between said energy terminal means and a selected portion of the electronic circuitry.
  • said means for gradually increasing the amplitude includes: input and output terminals for connection, respectively, to said energy terminal means and the selected portion of the electronic circuitry; amplifier means connected between said input and output terminals and having a control terminal; electrical time constant means; and means connecting said time constant means to said control terminal and across said energy terminal means.
  • said electrical time constant means comprises: resistance means and capacitance means; means for connecting said resistance means between said control terminal and one polarity of said energy terminal means; and means for connecting said capacitance means between said control terminal and another polarity of said energy terminal means.
  • said amplifier means comprises: a transistor having input and output electrodes connected to said input and output terminals, and having a control electrode connected to said control terminal.
  • the stimulator adapted to be connected to a source of electrical energy and including pulse generator means and output amplitude control means
  • the improvement comprising: energy terminal means adapted to be connected to the source of electrical energy; means for automatically gradually increasing the amplitude of the initial pulses of the output train of pulses to a predetermined value; and means for connecting said means for gradually increasing the amplitude between said energy terminal means and the output amplitude control means.
  • said means for gradually increasing the amplitude includes: amplifier means connected between said energy terminal means and the output means for connecting said time constant means across said energy terminal means; and means connecting said time constant means to said amplifier means for the control thereof.
  • said electrical time constant means comprises: resistance means and capacitance means connected in series across said energy terminal means; and said capacitance means connected to said amplifier means for controlling the output thereof dependent on the electrical charge in said capacitance means.
  • said amplifier means comprises: a transistor having input, output and control electrodes; said input and output electrodes connected to, respectively, said energy terminal means and said output amplitude control means; and said control electrode connected to said capacitance means.
  • a carotid sinus nerve stimulator for providing stimulating signals to a selected nerve fiber between being turned on and turned 05, the improvement comprising: means automatically responsive to the stimulator being turned on for gradually increasing the amplitude of the initial stimulating signals to a predetennined level maintained until the stimulator is turned off; said means comprising time constant means connected to control the initial current flow through at least a position of the nerve stimulator; and including energy terminal means adapted to be connected to a source of energy; and said time constant means comprising an RC circuit connected between at least a position of the nerve stimulator and said terminal means.
  • Transistor emitter-follower connected should be -emitt,erfollowe r connected transistor--.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Abstract

Electronic circuitry for providing electrical stimulation signals to a selected portion of the body including circuitry for automatically gradually increasing the amplitude of only the initial output stimulating signals to a predetermined level which is maintained until turnoff.

Description

United States Patent [151 3,645,267
Hagfcrs Feb. 29, 1972 [54] MEDICAL-ELECTRONIC 2,866,461 12/1958 Suzuki.. ..l28/419 STIMULATOR, PARTICULARLY A 3,098,976 7/1963 Leakey ..307/293 CAROTID SINUS NERV-E STIMULATOR 3,376,429 4/1968 Atkins et al ..307/141 WITH CONTROLLED TURN-0N AMPLITUDE RATE [72] Inventor: Norman R. Hagfors, Minneapolis, Minn. [73] Assignee: Medtr0nic,1nc., Minneapolis, Minn. [22] Filed: Oct. 29, 1969 [21] Appl. No.: 872,150
[52] US. Cl. ..l28/421, 128/419 C, 307/141.4, 307/293, 328/77 [51] Int. Cl. ..A6ln 1/36 [58] Field oiSearch ..l28/419-422; 328/8, 9, 76, 77, 85, 90; 307/293, 141, 141.4
[56] References Cited UNITED STATES PATENTS 2,321,659 6/l943 Connerty et al. ...,,,..128/422 3,516,413 6/1970 McDonald etal. ..128/422 Primary Examiner-William E. Kamm Attorney-Lew Schwartz and Donald R. Stone [57] ABSTRACT .output stimulating signals to a predetermined level which is maintained until turnoff.
11 Claims, 4 Drawing Figures OUT PAIENIEDFEB 29 I972 3,645,267 SH'EET- 1 0r 2 ELECTRONIC PULSE STIMULATOR IIIIHHIIIHHIIIIIIIIIIIIIIIIHHIIIHIHHIIHlllIIIllIllHllllllllllllllllllllllllllIIHIIII AMPLITUDE TIME PRIOR ART PIES H mlllllllllllilllllllllINlllllIlHHlllllIIIIIIHIHIIIIIIIHIII AMPLITUDE l w'" I 1 nn INVIiNIOR. Moe/14441 E Aha/ oes BY MEDICAL-ELECTRONIC STIMULATOR, PARTICULARLY A CAROTID SINUS NERVE STIMULATOR WITH CONTROLLED TURN-ON AMPLITUDE RATE BACKGROUND OF THE INVENTION This invention is concerned with medical-electronic pulse stimulators, and more particularly with an improvement to automatically provide for the gradual increase of the amplitude of the initial output signals from the pulse stimulating circuitry. Electrical stimulation of nerves, muscles, or other tissue, for medical purposes, is well known in the art. Some examples of well-known circuitry are heart pacers and carotid sinus nerve stimulators. The electrical stimulation of nerves, muscles or other tissue is often accompanied by undesirable side effects caused by stimulation of adjacent nerve fibers, for example. It has been discovered that in many cases these side effects are transitory in nature and persist for only a short period of time after stimulus by means of electrical signals is first applied. It is theorized that the stimulating signals, when turned on at full stimulating amplitude, cause the afferent nerve fibers to fire giving a sensation of electrical shock. It appears that these afferent fibers then accommodate to the stimulus signal, and will no longer fire.
The apparatus of this invention overcomes the above-mentioned undesirable side effects by providing circuitry for gradually increasing the amplitude of the initial stimulating signals to a predetermined stimulus level. It has been found that if the stimulus is turned on gradually, the afferent nerve fibers accommodate to the stimulus signal without depolarizing and provide little or no sensation of electrical shock, and that the stimulating signals may thereafter be maintained at the predetermined level without adverse reaction. Therefore, the apparatus of this invention has been designed for implantable, transcutaneous, and external stimulators to provide pulse or other stimulus turn-on characteristics which will be accommodated by the afferent nerve fibers to prevent a transitory response.
SUMMARY OF THE INVENTION Briefly described, the apparatus of this invention comprises amplifier means connected between a selected portion or all of the circuitry for providing stimulating signals and the source of energy which provides the electrical power to the circuitry. The amplifier means is controlled by electrical time constant circuitry which is connected by switch means across the source of electrical energy. In the preferred embodiment of the drawings, the time constant means is shown as a serial RC circuit, that is, a resistor and a capacitor connected in series. When the switch is closed, the time constant causes a gradual buildup of charge in the capacitor. The charge on the capacitor is used to control the initial output of the amplifier which in turn controls the current reaching the circuitry for providing stimulating signals, in this circuit a train of pulses. By gradually increasing the initial output of the amplifier, the initial amplitude of the train of output pulses will also be gradually increased to its maximum or predetermined level. As described above, this gradual increase of the initial amplitude of the signals which provide stimulus will reduce or remove the transitory response that causes an uncomfortable feeling in the patient receiving the stimulation.
IN THE DRAWINGS FIG. 1 is a combination schematic and block diagram showing an embodiment using the apparatus of this invention;
FIG. 2 is a schematic diagram of electronic pulse stimulating circuitry using another embodiment of the apparatus of this invention;
FIG. 3 is a graph indicating a typical envelope for a train of prior art stimulating pulses; and
FIG. 4 is a graph indicating the envelope of a train of stimulating pulses provided by the apparatus of this invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS In FIG. 1 there is shown in block diagram an electronic stimulator 10. Stimulator 10 has a pair of input terminals 11 and 12 adapted to be connected to a source of electrical energy, and a pair of output terminals 13 and 14 across which the stimulator provides a train of output pulses. A source of electrical energy, here shown as batteries 15, is connected between input terminal 11 and one side of a switch 16. The ap paratus of this invention for gradually increasing the initial output amplitude of the stimulating signals is shown enclosed within dotted lines and indicated generally as 20. Apparatus 20 comprises a capacitor 17 and resistor 18 serially connected across source 15 and switch 16. Apparatus 20 also includes a transistor 19, having an emitter connected to input terminal 12, a collector connected to the other side of switch 16, and a base connected to a junction between capacitor 17 and resistor 18.
To best understand the operation of the apparatus of FIG. i, assume first that switch 16 is open. Therefore, there will be no charge on capacitor 17 and no output signals from stimulator 10. When output signals are desired, switch 16 is closed. This will connect the electrical time constant apparatus, comprising the serial RC circuit of capacitor 17 and resistor 18, across source 15. As capacitor 17 cannot charge instantaneously, there will be no current flow through the amplifier comprising transistor 19, and therefore no power to stimulator l0, instantaneously.
As the electrical time constant apparatus remains connected across source 15, a charge will buildup in capacitor 17 I and the resulting voltage change at the junction between capacitor 17 and resistor 18 will be felt on the base of the amplifier comprising transistor 19 to turn it on and provide a current flow through terminals 11 and 12 to stimulator 10. This current flow will allow operation of the electronic stimulator 10 which will in turn provide the desired train of output signals. As the charge across capacitor 17 continues to gradually increase, the current fiow through transistor emitter-follower connected 19 will also gradually increase until the maximum current fiow from source 15 is reached. During this time the resulting gradual increase of current flow to stimulator 10 will cause a corresponding gradual increase in the output amplitude of the initial signals. This gradual increase of the amplitude of only the initial output signals to a maximum or predetermined amplitude is the desired result to alleviate the undesirable feelings caused in the patient receiving the train of pulses, which undesirable feeling is present when the initial turn-on of the train of pulses is at full amplitude and is apparently caused by stimulation of adjacent nerve fibers.
Referring now to FIG. 2 there is shown another embodiment of the apparatus of this invention. In FIG. 2 the disclosed schematic is that of a radiofrequency pulse transmitter of a type presently in use in the art, for transmitting a train of stimulating pulses via RF to an implanted receiver which is connected to the tissue that is to be stimulated.
In FIG. 2, output terminals 13 and 14, source 15 and switch 16 bear the same numbers as for FIG. 1. Also, the improvement comprising the apparatus of this invention is again enclosed in dotted lines and denoted as 20. Source 15 has one terminal connected to a positive bus 21, and another terminal connected through switch 16 to a negative bus 22. A capacitor 23, for voltage stabilization purposes, is connected between buses 21 and 22. A transistor 24 has its emitter connected to bus 21. The base of transistor 24 is connected through a pair of diodes 25 and 26 to bus 21, and through a resistor 27 and a variable resistor 28 to bus 22. A transistor 30 has its emitter connected to bus 22. The base of transistor 30 is connected through a resistor 33 to the collector of transistor 24, and through a resistor 34 to bus 22. The collector of transistor 30 is connected through a resistor 32 and a capacitor 31 to the base of transistor 24. A transistor 35 has its emitter connected to bus 21. The base of transistor 35 is connected through a resistor 36 to the collector of transistor 30, and through a resistor 37 to bus 21. The collector of transistor 35 is connected through a serial combination of a resistor 38 and a Zener diode 39 to bus 22. A junction between resistor 38 and diode 39 is connected to bus 22 through a serial combination of a potentiometer 40 and a resistor 41. A transistor 42 has its base connected to the wiper arm of potentiometer 40, and its emitter connected through a resistor 43 to a junction 44. Junction 44 is connected through a capacitor 45 to bus 22, and directly to output terminal 13. A pair of serially connected resistors 46 and 47 are connected between junction 44 and bus 22. A transistor 50 has its base connected to a junction between resistors 46 and 47, and its collector connected directly to output terminal 14. A capacitor 51 is connected between the collector and emitter of transistor 50. The emitter of transistor 50 is connected through an RF tank circuit 53 to bus 22. Tank circuit 53 comprises a parallel combination of a variable inductance 54, a capacitor 55 and a capacitor 56.
The apparatus of this invention is connected as follows: a transistor 60 has its emitter connected to the collector of transistor 42. The collector of transistor 60 is connected to bus 21. The base of transistor 60 is connected through a resistor 61 to bus 21, and through a capacitor 62 to bus 22. A capacitor 63 is connected between the emitter of transistor 60 and bus 22 to provide lower circuit impedance in a manner well known in the art.
In reviewing the operation of the apparatus of FIG. 2, it will be apparent to one of normal skill in the art that transistors 24 and 30 and their associated electrical components comprise a pulse generator that will act to provide output pulses as long as switch 16 is closed. When switch 16 is closed the voltage from source 15 will be felt between buses 21 and 22. There will be a current flow through diodes 25 and 26, resistor 27 and variable resistor 28. Capacitor 31 will not be charged, and the drop across diodes 25 and 26 will forward bias the emitter-base junction of transistor 24 to turn it on. The tum-on of transistor 24 will cause a current flow through resistors 33 and 34 thus causing a forward bias at the emitter-base junction of transistor to turn it on. When transistor 30 turns on a charging path will be provided for capacitor 31, and when the charge on capacitor 31 has reached a sufficient level it will bias off transistor 24, which will in turn bias off transistor 30. The charge on capacitor 31' will then discharge through the path comprising resistor 37, resistor 36, resistor 32, capacitor 31, resistor 27 and resistor 28. When a sufficient lowering of the charge on capacitor 31 has been accomplished transistor 24 will again turn on and the cycle will repeat. Thus there is an output train of pulses generated as long as switch 16 is closed.
It will also be apparent to one of normal skill in the art that transistor 35 and Zener diode 39, along with their associated electrical components, comprise a voltage regulator. Operating in a manner apparent to one of normal skill in the art, the output pulse from the pulse generator causes a current flow through resistors 36 and 37 to forward bias the emitter-base junction of transistor 35 thus causing a current flow through resistor 38, potentiometer and resistor 41. Diode 39 acts to regulate the voltage of this portion of the circuit.
Transistor 42 in combination with potentiometer 40 operate as an output amplitude adjustment, with the capability of varying the amplitude of the output according to the positioning of the wiper arm of potentiometer 40. Assuming first that the apparatus 20 is not present, and that, as in the prior art, the collector of transistor 42 is connected directly to bus 21, then the current flow through transistor 40 will cause the forward biasing of the emitter-base junction of transistor 42, causing a current flow through resistor 43 to junction 44. This will charge transistor 45 and be felt across the serial combination of resistors 46 and 47. Transistor 50 will then be turned on to provide energy to the tank circuit 53 and the RF oscillator interconnection of these components will cause a train of RF output pulses at terminals 13 and 14, the amplitude of which is controlled by the setting of potentiometer 40.
Returning now to the apparatus of FIG. 2, in which the apparatus 20 is present, it can be seen that the output of transistor 42 will not be provided to the RF oscillator until the amplifier comprising transistor 60 has been turned on. It can also be seen that the time constant apparatus, comprising the serial combination of resistor 61 and capacitor 62 across the power supply, controls the tum-on of transistor emitter-follower connected 60. That is, when switch 16 is closed there will have been no charge on capacitor 62 and there will therefore not be an instantaneous forward biasing of the emitterbase junction of transistor 60. As capacitor 62 gradually charges through resistor 61, the forward bias of the emitterbase junction of transistor 60 will gradually increase, and the current flow therethrough to the collector of transistor 42 will correspondingly gradually increase. When capacitor 62 is fully charged then the maximum current flow will be available through transistor 60 and transistor 42.
It thus becomes apparent that the amplitude of the initial pulses available through transistor 42 to the RF oscillator is gradually increased, and that only the initial pulses of the resulting train of RF pulses will be correspondingly gradually increased. Thus the RF receiver which is connected to the tissue of the patient will receive a train of pulses of which the initial pulses gradually increase in amplitude to a predetermined value, and the possibility of an unpleasant feeling due to the transitory side effects caused by the immediate full amplitude tum-on of the train of pulses will be alleviated.
In testing the apparatus of FIGS. 1 and 2, it has been determined, for the RF pulse transmitter of FIG. 2, that the connection of apparatus 20 at the position in the circuitry as shown in FIG. 2 is preferable to that of FIG. 1 for purposes of conservation of energy. The connection possibility suggested in the embodiment of FIG. 1, that is, where the apparatus 20 is placed between the source of energy 15 and all of circuitry 10, is be lieved to be the preferred embodiment for purposes of stability. Other embodiments than those shown in the drawings have been used, for example the placement of apparatus 20 so as to provide gradual increase of power supply voltage to both the voltage regulator and output amplitude adjustment apparatus of FIG. 2, and it will be apparent that the placement of apparatus 20 to select gradual control of any selected portion of the pulse stimulator circuitry is in any case within the scope of this invention.
FIGS. 3 and 4 are graphs of the pulse train amplitude versus time for representing the difference between the prior an output pulse trains and the pulse trains from apparatus utilizing this invention. FIG. 3 is a prior art output pulse train where it can be seen that almost instantaneously the train of pulses reaches its full amplitude. It is this sudden rise to full amplitude which is believed to cause the side effects and unpleasant feelings'in the patient, probably due to stimulation of adjacent tissue to the tissue it is desired to stimulate. FIG. 4, a graph on the same scale as FIG. 3, depicts the gradual rise to full amplitude of the initial pulses of the output pulse train of stimulators including the invention disclosed herein. It is believed that with this gradual turn-on of only the initial portion of the stimulating signals, the adjacent fibers will accommodate to the stimulus signals without depolarizing and will provide little or no sensation to the patient.
What is claimed is:
1. In electronic circuitry for providing output electronic stimulating signals to a selected portion of the body the signals providing a plurality of pulses, the circuitry adapted to be connected to a source of electrical energy, the improvement comprising: means for gradually increasing the amplitude of the initial pulses of the output stimulating signals to a predetermined value; energy terminal means adapted to be connected to the source of electrical energy; and further means for connecting said means for gradually increasing the amplitude between said energy terminal means and a selected portion of the electronic circuitry.
2. The improvement of claim 1 in which said means for gradually increasing the amplitude includes: input and output terminals for connection, respectively, to said energy terminal means and the selected portion of the electronic circuitry; amplifier means connected between said input and output terminals and having a control terminal; electrical time constant means; and means connecting said time constant means to said control terminal and across said energy terminal means.
3. The improvement of claim 2 in which said electrical time constant means comprises: resistance means and capacitance means; means for connecting said resistance means between said control terminal and one polarity of said energy terminal means; and means for connecting said capacitance means between said control terminal and another polarity of said energy terminal means.
4. The improvement of claim 3 in which said amplifier means comprises: a transistor having input and output electrodes connected to said input and output terminals, and having a control electrode connected to said control terminal.
5. The improvement of claim 4 in which said transistor is connected in emitter-follower configuration.
6. in electronic pulse stimulator apparatus for providing an output train of pulses, the stimulator adapted to be connected to a source of electrical energy and including pulse generator means and output amplitude control means, the improvement comprising: energy terminal means adapted to be connected to the source of electrical energy; means for automatically gradually increasing the amplitude of the initial pulses of the output train of pulses to a predetermined value; and means for connecting said means for gradually increasing the amplitude between said energy terminal means and the output amplitude control means.
7. The improvement of claim 6 in which said means for gradually increasing the amplitude includes: amplifier means connected between said energy terminal means and the output means for connecting said time constant means across said energy terminal means; and means connecting said time constant means to said amplifier means for the control thereof.
8. The improvement of claim 7 in which said electrical time constant means comprises: resistance means and capacitance means connected in series across said energy terminal means; and said capacitance means connected to said amplifier means for controlling the output thereof dependent on the electrical charge in said capacitance means.
9. The improvement of claim 8 in which said amplifier means comprises: a transistor having input, output and control electrodes; said input and output electrodes connected to, respectively, said energy terminal means and said output amplitude control means; and said control electrode connected to said capacitance means.
10. The improvement of claim 9 in which said transistor is connected in emitter-follower configuration.
11. in a carotid sinus nerve stimulator for providing stimulating signals to a selected nerve fiber between being turned on and turned 05, the improvement comprising: means automatically responsive to the stimulator being turned on for gradually increasing the amplitude of the initial stimulating signals to a predetennined level maintained until the stimulator is turned off; said means comprising time constant means connected to control the initial current flow through at least a position of the nerve stimulator; and including energy terminal means adapted to be connected to a source of energy; and said time constant means comprising an RC circuit connected between at least a position of the nerve stimulator and said terminal means.
R 3 331 UNITED STATES PA'l-ENT OFFICE CERTIFICATE OF "CORRECTION Patent No.- 3,645,267 Dated February 29 1972 Inventor(s) Norman R. Hragfors It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Abstract, "turnoff" should be -turnoff-'-. Y Column 1, line 14 "well-known" should be --well known-. Column 2 line 39, "transistor emitter-follower connected". should be ---e mitter -fol'lower connected. transistor w Column 2, line 55,. "radiofrequency" should be -radio frequency-. Column '4, line 7,, "transistor emitter-follower connected" should be -emitterfollower connected transistor--. Column 6, line 28, "position" should be portion. Column 6, line 31, "position" should be portion--.
, Signed and sealed this 27th dayv of June 1972. v
(SEAL) Attest:
EWARD M.FLETCHER,J'R. ROBERT GOTTSCHALK Attesting Officer Commissioner of Patents *zgygga UNITED STATES PATENT OFFICE CERTIFICATE OF "CORRECTION Patent No. 3,645,267 Dated February 29, 1972 Inventor(s) Norman R. Hagfors Itis certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Abstract, "turnoff" should be turnoff-. Y I Column 1, line 14 "well-known" should be -.Well known. Column 2, line 39, "transistor emitter-follower connected". should be -emitterfol'lower connected transistor.-
Column 2 line 55,. "radiofrequency" should be -radio frequency-.
Column 4 line 7,, "transistor emitter-follower connected" should be -emitt,erfollowe r connected transistor--.
Column 6 line 28, "position" should be -portion.
Column 6, line 31, "position" should be -portion.
Signed and sealed this 27th day of June 1972. v
(SEAL) Attest:
EDWARD M.FLETCHER,J'R. ROBERT GOTTSCHAIK Attesting Officer Commissioner of Patents

Claims (11)

1. In electronic circuitry for providing output electronic stimulating signals to a selected portion of the body the signals providing a plurality of pulses, the circuitry adapted to be connected to a source of electrical energy, the improvement comprising: means for gradually increasing the amplitude of the initial pulses of the output stimulating signals to a predetermined value; energy terminal means adapted to be connected to the source of electrical energy; and further means for connecting said means for gradually increasing the amplitude between said energy terminal means and a selected portion of the electronic circuitry.
2. The improvement of claim 1 in which said means for gradually increasing the amplitude includes: input and output terminals for connection, respectively, to said energy terminal means and the selected portion of the electronic circuitry; amplifier means connected between said input and output terminals and having a control terminal; electrical time constant means; and means connecting said time constant means to said control terminal and across said energy terminal means.
3. The improvement of claim 2 in which said electrical time constant means comprises: resistance means and capacitance means; means for connecting said resistance means between said control terminal and one polarity of said energy terminal means; and means for connecting said capacitance means between said control terminal and another polarity of said energy terminal means.
4. The improvement of claim 3 in which said amplifier means comprises: a transistor having input and output electrodes connected to said input and output terminals, and having a control electrode connected to said control terminal.
5. The improvement of claim 4 in which said transistor is connected in emitter-follower configuration.
6. In electronic pulse stimulator apparatus for providing an output train of pulses, the stimulator adapted to be connected to a source of electrical energy and including pulse generator means and output amplitude control means, the improvement comprising: energy terminal means adapted to be connected to the source of electrical energy; means for automatically gradually increasing the amplitude of the initial pulses of the output train of pulses to a predetermined value; and means for connecting said means for gradually increasing the amplitude between said energy terminal means and the output amplitude control means.
7. The improvement of claim 6 in which said means for gradually increasing the amplitude includes: amplifier means connected between said energy terminal means and the output amplitude control means; electrical time constant means; means for connecting said time constant means across said energy terminal means; and means connecting said time constant means to said amplifier means for the control thereof.
8. The improvement of claim 7 in which said electrical time constant means comprises: resistance means and capacitance means connected in series across said energy terminal means; and said capacitance means connected to said amplifier means for controlling the output thereof dependent on the electrical charge in said capacitance means.
9. The improvement of claim 8 in which said amplifier means comprises: a transistor having input, output and control electrodes; said input and output electrodes connected to, respectively, said energy terminal means and said output amplitude control means; and said control electrode connected to said capacitance means.
10. The improvement of claim 9 in which said transistor is connected in emitter-follower configuration.
11. In a carotid sinus nerve stimulator for providing stimulating signals to a selected nerve fiber between being turned on and turned off, the improvement comprising: means automatically responsive to the stimulator being turned on for gradually increasing the amplitude of the initial stimulating signals to a predetermined level maintained until the stimulator is turned off; said means comprising time constant means connected to control the initial current flow through at least a position of the nerve stimulator; and including energy terminal means adapted to be connected to a source of energy; and said time constant means comprising an RC circuit connected between at least a position of the nerve stimulator and said terminal means.
US3645267D 1969-10-29 1969-10-29 Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate Expired - Lifetime US3645267A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87215069A 1969-10-29 1969-10-29

Publications (1)

Publication Number Publication Date
US3645267A true US3645267A (en) 1972-02-29

Family

ID=25358947

Family Applications (1)

Application Number Title Priority Date Filing Date
US3645267D Expired - Lifetime US3645267A (en) 1969-10-29 1969-10-29 Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate

Country Status (4)

Country Link
US (1) US3645267A (en)
DE (1) DE2049498A1 (en)
FR (1) FR2066555A5 (en)
NL (1) NL7014756A (en)

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836798A (en) * 1970-05-11 1974-09-17 Greatbatch W Ltd Device for converting nuclear energy into electrical energy
US3920025A (en) * 1974-07-15 1975-11-18 Medtronic Inc Electro-medical stimulator system
US4066086A (en) * 1975-06-05 1978-01-03 Medtronic, Inc. Programmable body stimulator
US4102348A (en) * 1976-05-19 1978-07-25 Kabushiki Kaisha Nippon Coinco Low frequency medical treatment apparatus
US4177819A (en) * 1978-03-30 1979-12-11 Kofsky Harvey I Muscle stimulating apparatus
US4233965A (en) * 1978-01-16 1980-11-18 Cas Products, Inc. Method and apparatus for the therapeutic treatment of living tissue
EP0033747A1 (en) * 1979-06-15 1981-08-19 Matsushita Electric Works, Ltd. Low frequency therapeutic device
DE3049643A1 (en) * 1979-06-15 1982-02-25 Matsushita Electric Works Ltd LOW FREQUENCY THERAPEUTIC DEVICE
US4323073A (en) * 1978-09-11 1982-04-06 Cos Electronics Corporation Apparatus and method for controlling the application of therapeutic direct current to living tissue
EP0052087A1 (en) * 1980-11-12 1982-05-19 Fiorello Sodi Process and apparatus for the correction of scoliosis and other spinal deformities
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
DE3315513A1 (en) * 1982-04-30 1983-11-03 Medtronic, Inc., 55440 Minneapolis, Minn. DIGITAL CIRCUIT ARRANGEMENT FOR CONTROLLING AN EVERY TIME TURNING ON ELECTRIC TISSUE IRON DEVICES
US4630615A (en) * 1984-05-21 1986-12-23 Cordis Corporation Apparatus for measuring impedance
US4735204A (en) * 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
US4738250A (en) * 1985-10-01 1988-04-19 Mems Technology, Incorporated Apparatus and method for micro-electric medical stimulation of cells of living animal tissue
US4769881A (en) * 1986-09-02 1988-09-13 Pedigo Irby R High precision tens apparatus and method of use
USRE33420E (en) * 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US5146920A (en) * 1989-11-20 1992-09-15 Sanyo Electric Co., Ltd. Wireless low-frequency medical treatment device with pulse interruption based upon electrode contact with the body
US5184617A (en) * 1990-06-05 1993-02-09 Staodyn, Inc. Output pulse compensation for therapeutic-type electronic devices
US5193537A (en) * 1990-06-12 1993-03-16 Zmd Corporation Method and apparatus for transcutaneous electrical cardiac pacing
US5205284A (en) * 1990-06-12 1993-04-27 Zoll Medical Corporation Method and apparatus for transcutaneous electrical cardiac pacing with background stimulation
US5243232A (en) * 1991-07-31 1993-09-07 Allen-Bradley Company, Inc. Start-up pulse suppression circuit for industrial controller output
US5727558A (en) * 1996-02-14 1998-03-17 Hakki; A-Hamid Noninvasive blood pressure monitor and control device
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6107699A (en) * 1998-05-22 2000-08-22 Scimed Life Systems, Inc. Power supply for use in electrophysiological apparatus employing high-voltage pulses to render tissue temporarily unresponsive
FR2797773A1 (en) 1999-09-01 2001-03-02 Aloha ELECTRICAL STIMULATION OF THE LYMPHATIC SYSTEM AND ITS APPLICATIONS
US6428537B1 (en) 1998-05-22 2002-08-06 Scimed Life Systems, Inc. Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive
US20020107553A1 (en) * 2000-10-26 2002-08-08 Medtronic, Inc. Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US20020143369A1 (en) * 2000-10-26 2002-10-03 Medtronic, Inc. Method and apparatus to minimize effects of a cardiac insult
US6522926B1 (en) 2000-09-27 2003-02-18 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US20030074037A1 (en) * 2001-10-17 2003-04-17 Rehabilicare, Inc. Electrical nerve stimulation device
US20030100924A1 (en) * 2001-04-20 2003-05-29 Foreman Robert D. Cardiac neuromodulation and methods of using same
US20040019364A1 (en) * 2000-09-27 2004-01-29 Cvrx, Inc. Devices and methods for cardiovascular reflex control via coupled electrodes
US20040127953A1 (en) * 2001-02-20 2004-07-01 Kilgore Kevin L. Systems and methods for reversibly blocking nerve activity
US20040254616A1 (en) * 2000-09-27 2004-12-16 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6850801B2 (en) 2001-09-26 2005-02-01 Cvrx, Inc. Mapping methods for cardiovascular reflex control devices
US20060004417A1 (en) * 2004-06-30 2006-01-05 Cvrx, Inc. Baroreflex activation for arrhythmia treatment
US6985774B2 (en) 2000-09-27 2006-01-10 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US20060111626A1 (en) * 2003-03-27 2006-05-25 Cvrx, Inc. Electrode structures having anti-inflammatory properties and methods of use
US7158832B2 (en) 2000-09-27 2007-01-02 Cvrx, Inc. Electrode designs and methods of use for cardiovascular reflex control devices
US20070021796A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Baroreflex modulation to gradually decrease blood pressure
US20070038259A1 (en) * 2000-09-27 2007-02-15 Cvrx, Inc. Method and apparatus for stimulation of baroreceptors in pulmonary artery
US7218964B2 (en) 2000-10-26 2007-05-15 Medtronic, Inc. Closed-loop neuromodulation for prevention and treatment of cardiac conditions
US20070161912A1 (en) * 2006-01-10 2007-07-12 Yunlong Zhang Assessing autonomic activity using baroreflex analysis
US20070191895A1 (en) * 2001-04-20 2007-08-16 Foreman Robert D Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure
US20080167699A1 (en) * 2000-09-27 2008-07-10 Cvrx, Inc. Method and Apparatus for Providing Complex Tissue Stimulation Parameters
US20080177365A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Method and apparatus for electronically switching electrode configuration
US20080208286A1 (en) * 2003-10-22 2008-08-28 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US20090132002A1 (en) * 2007-05-11 2009-05-21 Cvrx, Inc. Baroreflex activation therapy with conditional shut off
US20090276022A1 (en) * 2008-04-30 2009-11-05 Medtronic , Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20100114201A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114203A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114224A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114221A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US20100114211A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US20100114198A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114205A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US20100114208A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114199A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114200A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114202A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114197A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100138340A1 (en) * 2002-09-19 2010-06-03 John Earl Shirey System and apparatus for transaction fraud processing
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US20110166482A1 (en) * 2008-03-27 2011-07-07 Stack Richard S System and method for transvascularly stimulating contents of the carotid sheath
US8249705B1 (en) 2007-03-20 2012-08-21 Cvrx, Inc. Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy
US8452394B2 (en) 2008-10-31 2013-05-28 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8594794B2 (en) 2007-07-24 2013-11-26 Cvrx, Inc. Baroreflex activation therapy with incrementally changing intensity
USRE45718E1 (en) * 2001-02-20 2015-10-06 Boston Scientific Corporation Systems and methods for reversibly blocking nerve activity

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418248B (en) * 1978-11-23 1981-05-18 Tekniska Roentgencentralen Ab DEVICE FOR DESTRUCTING A BIOLOGICAL TISSUE PARTY
DE3216911A1 (en) * 1982-05-06 1983-11-10 Datron-Electronic Pichl & Schulte KG, 6109 Mühltal Domiciliary apparatus for electro-therapeutic treatment

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321659A (en) * 1941-02-03 1943-06-15 Harold V Connerty Variable frequency stimulator
US2866461A (en) * 1950-10-23 1958-12-30 Suzuki Kensaku Apparatus for producing electric anesthesia
US3098976A (en) * 1959-04-20 1963-07-23 Gen Electric Co Ltd Low cross-talk delay circuit
US3376429A (en) * 1965-06-04 1968-04-02 Wagner Electric Corp Time delay circuit
US3516413A (en) * 1965-05-26 1970-06-23 Michael Mcdonald Circuit arrangement for an electric muscle stimulator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321659A (en) * 1941-02-03 1943-06-15 Harold V Connerty Variable frequency stimulator
US2866461A (en) * 1950-10-23 1958-12-30 Suzuki Kensaku Apparatus for producing electric anesthesia
US3098976A (en) * 1959-04-20 1963-07-23 Gen Electric Co Ltd Low cross-talk delay circuit
US3516413A (en) * 1965-05-26 1970-06-23 Michael Mcdonald Circuit arrangement for an electric muscle stimulator
US3376429A (en) * 1965-06-04 1968-04-02 Wagner Electric Corp Time delay circuit

Cited By (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836798A (en) * 1970-05-11 1974-09-17 Greatbatch W Ltd Device for converting nuclear energy into electrical energy
US3920025A (en) * 1974-07-15 1975-11-18 Medtronic Inc Electro-medical stimulator system
US4066086A (en) * 1975-06-05 1978-01-03 Medtronic, Inc. Programmable body stimulator
US4102348A (en) * 1976-05-19 1978-07-25 Kabushiki Kaisha Nippon Coinco Low frequency medical treatment apparatus
US4233965A (en) * 1978-01-16 1980-11-18 Cas Products, Inc. Method and apparatus for the therapeutic treatment of living tissue
US4177819A (en) * 1978-03-30 1979-12-11 Kofsky Harvey I Muscle stimulating apparatus
US4323073A (en) * 1978-09-11 1982-04-06 Cos Electronics Corporation Apparatus and method for controlling the application of therapeutic direct current to living tissue
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
EP0033747A1 (en) * 1979-06-15 1981-08-19 Matsushita Electric Works, Ltd. Low frequency therapeutic device
EP0033747A4 (en) * 1979-06-15 1981-10-13 Matsushita Electric Works Ltd Low frequency therapeutic device.
DE3049643A1 (en) * 1979-06-15 1982-02-25 Matsushita Electric Works Ltd LOW FREQUENCY THERAPEUTIC DEVICE
US4372319A (en) * 1979-06-15 1983-02-08 Matsushita Electric Works, Ltd. Low frequency therapeutic instrument
EP0052087A1 (en) * 1980-11-12 1982-05-19 Fiorello Sodi Process and apparatus for the correction of scoliosis and other spinal deformities
DE3315513A1 (en) * 1982-04-30 1983-11-03 Medtronic, Inc., 55440 Minneapolis, Minn. DIGITAL CIRCUIT ARRANGEMENT FOR CONTROLLING AN EVERY TIME TURNING ON ELECTRIC TISSUE IRON DEVICES
US4520825A (en) * 1982-04-30 1985-06-04 Medtronic, Inc. Digital circuit for control of gradual turn-on of electrical tissue stimulators
US4630615A (en) * 1984-05-21 1986-12-23 Cordis Corporation Apparatus for measuring impedance
US4735204A (en) * 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
USRE33420E (en) * 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US4738250A (en) * 1985-10-01 1988-04-19 Mems Technology, Incorporated Apparatus and method for micro-electric medical stimulation of cells of living animal tissue
US4769881A (en) * 1986-09-02 1988-09-13 Pedigo Irby R High precision tens apparatus and method of use
US5146920A (en) * 1989-11-20 1992-09-15 Sanyo Electric Co., Ltd. Wireless low-frequency medical treatment device with pulse interruption based upon electrode contact with the body
US5184617A (en) * 1990-06-05 1993-02-09 Staodyn, Inc. Output pulse compensation for therapeutic-type electronic devices
USRE35987E (en) * 1990-06-05 1998-12-08 Staodyn, Inc. Output pulse compensation for therapeutic-type electronic devices
US5205284A (en) * 1990-06-12 1993-04-27 Zoll Medical Corporation Method and apparatus for transcutaneous electrical cardiac pacing with background stimulation
US5282843A (en) * 1990-06-12 1994-02-01 Zmd Corporation Electrodes and method for transcutaneous cardiac pacing
US5193537A (en) * 1990-06-12 1993-03-16 Zmd Corporation Method and apparatus for transcutaneous electrical cardiac pacing
US5243232A (en) * 1991-07-31 1993-09-07 Allen-Bradley Company, Inc. Start-up pulse suppression circuit for industrial controller output
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6212426B1 (en) 1995-07-28 2001-04-03 Scimed Life Systems, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6421556B2 (en) 1995-07-28 2002-07-16 Scimed Life Systems, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6679269B2 (en) 1995-07-28 2004-01-20 Scimed Life Systems, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US5727558A (en) * 1996-02-14 1998-03-17 Hakki; A-Hamid Noninvasive blood pressure monitor and control device
US6107699A (en) * 1998-05-22 2000-08-22 Scimed Life Systems, Inc. Power supply for use in electrophysiological apparatus employing high-voltage pulses to render tissue temporarily unresponsive
US6428537B1 (en) 1998-05-22 2002-08-06 Scimed Life Systems, Inc. Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive
FR2797773A1 (en) 1999-09-01 2001-03-02 Aloha ELECTRICAL STIMULATION OF THE LYMPHATIC SYSTEM AND ITS APPLICATIONS
WO2001015772A1 (en) 1999-09-01 2001-03-08 Aloha S.A. Apparatus for electrical stimulation of the lymphatic system and uses thereof
US20080177339A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Electrode contact configurations for cuff leads
US20080177366A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Cuff electrode arrangement for nerve stimulation and methods of treating disorders
US8290595B2 (en) 2000-09-27 2012-10-16 Cvrx, Inc. Method and apparatus for stimulation of baroreceptors in pulmonary artery
US8086314B1 (en) 2000-09-27 2011-12-27 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US8060206B2 (en) 2000-09-27 2011-11-15 Cvrx, Inc. Baroreflex modulation to gradually decrease blood pressure
US20040019364A1 (en) * 2000-09-27 2004-01-29 Cvrx, Inc. Devices and methods for cardiovascular reflex control via coupled electrodes
US6522926B1 (en) 2000-09-27 2003-02-18 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US20040254616A1 (en) * 2000-09-27 2004-12-16 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7949400B2 (en) 2000-09-27 2011-05-24 Cvrx, Inc. Devices and methods for cardiovascular reflex control via coupled electrodes
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6985774B2 (en) 2000-09-27 2006-01-10 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7813812B2 (en) 2000-09-27 2010-10-12 Cvrx, Inc. Baroreflex stimulator with integrated pressure sensor
US7801614B2 (en) 2000-09-27 2010-09-21 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US20100191303A1 (en) * 2000-09-27 2010-07-29 Cvrx, Inc. Automatic baroreflex modulation responsive to adverse event
US20100179614A1 (en) * 2000-09-27 2010-07-15 Kieval Robert S Devices and methods for cardiovascular reflex control
US7158832B2 (en) 2000-09-27 2007-01-02 Cvrx, Inc. Electrode designs and methods of use for cardiovascular reflex control devices
US20070021796A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Baroreflex modulation to gradually decrease blood pressure
US20070021797A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Baroreflex stimulation synchronized to circadian rhythm
US20070021799A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Automatic baroreflex modulation based on cardiac activity
US20070021792A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Baroreflex Modulation Based On Monitored Cardiovascular Parameter
US20070021794A1 (en) * 2000-09-27 2007-01-25 Cvrx, Inc. Baroreflex Therapy for Disordered Breathing
US20070038259A1 (en) * 2000-09-27 2007-02-15 Cvrx, Inc. Method and apparatus for stimulation of baroreceptors in pulmonary artery
US20070038260A1 (en) * 2000-09-27 2007-02-15 Cvrx, Inc. Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US20070038262A1 (en) * 2000-09-27 2007-02-15 Cvrx, Inc. Baroreflex stimulation system to reduce hypertension
US20070038261A1 (en) * 2000-09-27 2007-02-15 Cvrx, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US20070060972A1 (en) * 2000-09-27 2007-03-15 Cvrx, Inc. Devices and methods for cardiovascular reflex treatments
US20100174347A1 (en) * 2000-09-27 2010-07-08 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US8583236B2 (en) 2000-09-27 2013-11-12 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US8606359B2 (en) 2000-09-27 2013-12-10 Cvrx, Inc. System and method for sustained baroreflex stimulation
US8712531B2 (en) 2000-09-27 2014-04-29 Cvrx, Inc. Automatic baroreflex modulation responsive to adverse event
US20070167984A1 (en) * 2000-09-27 2007-07-19 Cvrx, Inc. Method and apparatus for stimulation of baroreceptors
US8718789B2 (en) 2000-09-27 2014-05-06 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US20070185543A1 (en) * 2000-09-27 2007-08-09 Cvrx, Inc. System and method for sustained baroreflex stimulation
US8838246B2 (en) 2000-09-27 2014-09-16 Cvrx, Inc. Devices and methods for cardiovascular reflex treatments
US8880190B2 (en) 2000-09-27 2014-11-04 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US9044609B2 (en) 2000-09-27 2015-06-02 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US7623926B2 (en) 2000-09-27 2009-11-24 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US20080167694A1 (en) * 2000-09-27 2008-07-10 Cvrx, Inc. Automatic neural stimulation based on activity
US20080167699A1 (en) * 2000-09-27 2008-07-10 Cvrx, Inc. Method and Apparatus for Providing Complex Tissue Stimulation Parameters
US20080172101A1 (en) * 2000-09-27 2008-07-17 Cvrx, Inc. Non-linear electrode array
US20080171923A1 (en) * 2000-09-27 2008-07-17 Cvrx, Inc. Assessing autonomic activity using baroreflex analysis
US20080177364A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Self-locking electrode assembly usable with an implantable medical device
US20080177349A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Apparatus and method for modulating the baroreflex system
US20080177365A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Method and apparatus for electronically switching electrode configuration
US20080177348A1 (en) * 2000-09-27 2008-07-24 Cvrx, Inc. Electrode contact configurations for an implantable stimulator
US7616997B2 (en) 2000-09-27 2009-11-10 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US9427583B2 (en) 2000-09-27 2016-08-30 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US20090234418A1 (en) * 2000-09-27 2009-09-17 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US7010345B2 (en) 2000-10-26 2006-03-07 Medtronic, Inc. Method and apparatus to minimize effects of a cardiac insult
US20020143369A1 (en) * 2000-10-26 2002-10-03 Medtronic, Inc. Method and apparatus to minimize effects of a cardiac insult
US8417334B2 (en) 2000-10-26 2013-04-09 Medtronic, Inc. Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US9656079B2 (en) 2000-10-26 2017-05-23 Medtronic, Inc. Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US20020107553A1 (en) * 2000-10-26 2002-08-08 Medtronic, Inc. Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US7218964B2 (en) 2000-10-26 2007-05-15 Medtronic, Inc. Closed-loop neuromodulation for prevention and treatment of cardiac conditions
US7389145B2 (en) * 2001-02-20 2008-06-17 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20040127953A1 (en) * 2001-02-20 2004-07-01 Kilgore Kevin L. Systems and methods for reversibly blocking nerve activity
USRE45718E1 (en) * 2001-02-20 2015-10-06 Boston Scientific Corporation Systems and methods for reversibly blocking nerve activity
US20110066200A1 (en) * 2001-04-20 2011-03-17 Foreman Robert D Cardiac neuromodulation and methods of using same
US10279180B2 (en) 2001-04-20 2019-05-07 The Board Of Regents Of The University Of Oklahoma Cardiac neuromodulation and methods of using same
US9072901B2 (en) 2001-04-20 2015-07-07 The Board Of Regents Of The University Of Oklahoma Cardiac neuromodulation and methods of using same
US7860563B2 (en) 2001-04-20 2010-12-28 The Board Of Regents Of The University Of Oklahoma Cardiac neuromodulation and methods of using same
US20030100924A1 (en) * 2001-04-20 2003-05-29 Foreman Robert D. Cardiac neuromodulation and methods of using same
US20070191895A1 (en) * 2001-04-20 2007-08-16 Foreman Robert D Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure
US20060111746A1 (en) * 2001-04-20 2006-05-25 Foreman Robert D Cardiac neuromodulation and methods of using same
US7769441B2 (en) 2001-04-20 2010-08-03 The Board Of Regents Of The University Of Oklahoma Cardiac neuromodulation and methods of using same
US20060111745A1 (en) * 2001-04-20 2006-05-25 Foreman Robert D Cardiac neuromodulation and methods of using same
US6850801B2 (en) 2001-09-26 2005-02-01 Cvrx, Inc. Mapping methods for cardiovascular reflex control devices
US20070106340A1 (en) * 2001-09-26 2007-05-10 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US20080097540A1 (en) * 2001-09-26 2008-04-24 Cvrx, Inc. Ecg input to implantable pulse generator using carotid sinus leads
US8019426B2 (en) 2001-10-17 2011-09-13 Encore Medical Asset Corporation Electrical nerve stimulation device
US20030074037A1 (en) * 2001-10-17 2003-04-17 Rehabilicare, Inc. Electrical nerve stimulation device
US20080114414A1 (en) * 2001-10-17 2008-05-15 Moore Gary L Electrical nerve stimulation device
US8131374B2 (en) 2001-10-17 2012-03-06 Encore Medical Asset Corporation Electrical nerve stimulation device
US7254444B2 (en) 2001-10-17 2007-08-07 Encore Medical Asset Corporation Electrical nerve stimulation device
US20100138340A1 (en) * 2002-09-19 2010-06-03 John Earl Shirey System and apparatus for transaction fraud processing
US20060111626A1 (en) * 2003-03-27 2006-05-25 Cvrx, Inc. Electrode structures having anti-inflammatory properties and methods of use
US8755907B2 (en) 2003-10-22 2014-06-17 Cvrx, Inc. Devices and methods for electrode implantation
US20110137374A1 (en) * 2003-10-22 2011-06-09 Kieval Robert S Devices and methods for electrode implantation
US8478414B2 (en) 2003-10-22 2013-07-02 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US8224437B2 (en) 2003-10-22 2012-07-17 Cvrx, Inc. Baroreflex activation for sedation and sleep
US20080208286A1 (en) * 2003-10-22 2008-08-28 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US8560076B2 (en) 2003-10-22 2013-10-15 Cvrx, Inc. Devices and methods for electrode implantation
US20090198294A1 (en) * 2004-06-30 2009-08-06 Rossing Martin A Baroreflex activation for arrhythmia treatment
US20060004417A1 (en) * 2004-06-30 2006-01-05 Cvrx, Inc. Baroreflex activation for arrhythmia treatment
US20070156198A1 (en) * 2004-06-30 2007-07-05 Cvrx, Inc. Coordinated therapy for disordered breathing including baroreflex modulation
US20090069738A1 (en) * 2005-12-29 2009-03-12 Cvrx, Inc. Electrode Structures Having Anti-Inflammatory Properties And Methods Of Use
US8109879B2 (en) 2006-01-10 2012-02-07 Cardiac Pacemakers, Inc. Assessing autonomic activity using baroreflex analysis
US9949668B2 (en) 2006-01-10 2018-04-24 Cardiac Pacemakers, Inc. Assessing autonomic activity using baroreflex analysis
US20070161912A1 (en) * 2006-01-10 2007-07-12 Yunlong Zhang Assessing autonomic activity using baroreflex analysis
US8249705B1 (en) 2007-03-20 2012-08-21 Cvrx, Inc. Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy
US20090132002A1 (en) * 2007-05-11 2009-05-21 Cvrx, Inc. Baroreflex activation therapy with conditional shut off
US8594794B2 (en) 2007-07-24 2013-11-26 Cvrx, Inc. Baroreflex activation therapy with incrementally changing intensity
US8369954B2 (en) 2008-03-27 2013-02-05 Synecor Llc System and method for transvascularly stimulating contents of the carotid sheath
US20110166482A1 (en) * 2008-03-27 2011-07-07 Stack Richard S System and method for transvascularly stimulating contents of the carotid sheath
US8532793B2 (en) 2008-04-30 2013-09-10 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276022A1 (en) * 2008-04-30 2009-11-05 Medtronic , Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8315713B2 (en) 2008-04-30 2012-11-20 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090275996A1 (en) * 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090275956A1 (en) * 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US9572982B2 (en) 2008-04-30 2017-02-21 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US9561369B2 (en) 2008-04-30 2017-02-07 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276025A1 (en) * 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8688210B2 (en) 2008-10-31 2014-04-01 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114221A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8527045B2 (en) 2008-10-31 2013-09-03 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US20100114202A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114217A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US20100114200A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114199A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8611996B2 (en) 2008-10-31 2013-12-17 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8260412B2 (en) 2008-10-31 2012-09-04 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114208A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114205A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US20100114198A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8774918B2 (en) 2008-10-31 2014-07-08 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114211A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8532779B2 (en) 2008-10-31 2013-09-10 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9026206B2 (en) 2008-10-31 2015-05-05 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US20100114224A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114203A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US20100114201A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9192769B2 (en) 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US20100114197A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8473057B2 (en) 2008-10-31 2013-06-25 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US9597505B2 (en) 2008-10-31 2017-03-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8452394B2 (en) 2008-10-31 2013-05-28 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9775987B2 (en) 2008-10-31 2017-10-03 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8005539B2 (en) 2008-10-31 2011-08-23 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8249708B2 (en) 2008-10-31 2012-08-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation

Also Published As

Publication number Publication date
DE2049498A1 (en) 1971-05-13
FR2066555A5 (en) 1971-08-06
NL7014756A (en) 1971-05-04

Similar Documents

Publication Publication Date Title
US3645267A (en) Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate
US4177819A (en) Muscle stimulating apparatus
US4340063A (en) Stimulation device
US3835865A (en) Body organ stimulator
US4121594A (en) Transcutaneous electrical nerve stimulator
US4431002A (en) Modulated deep afferent stimulator
US3713449A (en) Cardiac pacer with externally controllable variable width output pulse
US6128531A (en) Delivery of ICD shock capacitor energy via a controlled current source
US6760626B1 (en) Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system
US3941137A (en) Ambulatory stimulator
US4147171A (en) Transcutaneous pain control and/or muscle stimulating apparatus
US4324253A (en) Transcutaneous pain control and/or muscle stimulating apparatus
US5433737A (en) Method for the electrical stimulation of a group of muscles in order to improve their appearance, and apparatus for carrying out the method
US4327322A (en) Bidirectional current supply circuit
US3941136A (en) Method for artificially inducing urination, defecation, or sexual excitation
US3893463A (en) Dual channel stimulator
US4153059A (en) Urinary incontinence stimulator system
US3749100A (en) Suppository electrode structure
WO2005101660A1 (en) Voltage limited systems and methods
US4084595A (en) Transcutaneous nerve stimulator
US4062365A (en) Apparatus for generating applied electrical stimuli signals
US3693626A (en) Demand pacer with heart rate memory
US3871383A (en) Power supply
WO2005101661A1 (en) Systems and methods for providing amplitude selection for pulse generation
US4102347A (en) Electronic pain control system